A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

December 21, 2020

Study Completion Date

December 21, 2020

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL

BX002-A

bacteriophage cocktail

OTHER

Placebo

Trial Locations (1)

Medical Facility, Cincinnati

All Listed Sponsors

lead

BiomX, Inc.

INDUSTRY

NCT04737876 - A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults | Biotech Hunter | Biotech Hunter